The prognostic value of grade of regression and oncocytic change in rectal adenocarcinoma treated with neo-adjuvant chemoradiotherapy

Journal of Surgical Oncology

Volumn 105, Issue 2, 2012, Pages 130-134

  Roy, Paromita ^a,b   Serra, Stefano ^a,b   Kennedy, Erin ^a,b   Chetty, Runjan ^a,b  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Dworak Regression Grade; oncocytic change; rectal carcinoma; Tumor Regression Grade

Indexed keywords

CAPECITABINE; FLUOROURACIL; FOLINIC ACID; MITOMYCIN C;

ADJUVANT CHEMORADIOTHERAPY; ADULT; AGED; ARTICLE; CANCER CELL; CANCER COMBINATION CHEMOTHERAPY; CANCER GRADING; CANCER REGRESSION; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTINUOUS INFUSION; CYTOPATHOLOGY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; POSTOPERATIVE CARE; PREDICTIVE VALUE; PREDICTOR VARIABLE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; RECTUM CARCINOMA; RETROSPECTIVE STUDY; TREATMENT RESPONSE;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMORADIOTHERAPY, ADJUVANT; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HUMANS; LEUCOVORIN; MALE; MIDDLE AGED; MITOMYCIN; NEOADJUVANT THERAPY; NEOPLASM GRADING; NEOPLASM STAGING; NEOPLASM, RESIDUAL; POSTOPERATIVE CARE; RECTAL NEOPLASMS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84855351019     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.22073     Document Type: Article

References (27)

1. Bosset JF, Calais G, Mineur L, et al.: Enhanced tumorocidal effect of chemotherapy with preoperative radiotherapy for rectal cancer: Preliminary results-EORTC 22921. J Clin Oncol 2005; 23: 5620-5627.
2. Gerard JP, Conroy T, Bonnetain F, et al.: Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: Results of FFCD 9203. J Clin Oncol 2006; 24: 4620-4625. (Pubitemid 46630960)
3. Sauer R, Becker H, Hohenberger W, et al.: Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004; 351: 1731-1740.
4. Kapiteijn E, Marijnen CA, Nagtegaal ID, et al.: Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001; 345: 638-646.
5. Bouzourene H, Bosman FT, Matter M, et al.: Predictive factors in locally advanced rectal cancer treated with preoperative hyperfractionated and accelerated radiotherapy. Hum Pathol 2003; 34: 541-548. (Pubitemid 36750365)
6. Bouzourene H, Bosman FT, Seelentag W, et al.: Importance of tumor regression assessment in predicting the outcome in patients with locally advanced rectal carcinoma who are treated with preoperative radiotherapy. Cancer 2002; 94: 1121-1130. (Pubitemid 34150868)
7. Pucciarelli S, Capirci C, Emanuele U, et al.: Relationship between pathologic T-stage and nodal metastasis after preoperative chemoradiotherapy for locally advanced rectal cancer. Ann Surg Oncol 2005; 12: 111-116. (Pubitemid 40486618)
8. Ryan R, Gibbons D, Hyland JM, et al.: Pathological response following long-course neoadjuvant chemoradiotherapy for locally advanced rectal cancer. Histopathology 2005; 47: 141-146. (Pubitemid 41113116)
9. Ambrosini-Spaltro A, Salvi F, Betts CM, et al.: Oncocytic modifications in rectal adenocarcinomas after radio and chemotherapy. Virchows Arch 2006; 448: 442-448.
10. Rouzbahman M, Serra S, Chetty R,: Rectal adenocarcinoma with oncocytic features: Possible relationship with preoperative chemoradiotherapy. J Clin Pathol 2006; 59: 1039-1043. (Pubitemid 44570325)
11. Dworak O, Keilholz L, Hoffmann A,: Pathological features of rectal cancer after preoperative radiochemotherapy. Int J Colorectal Dis 1997; 12: 19-23. (Pubitemid 27138353)
12. Mandard AM, Dalibard F, Mandard JC, et al.: Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations. Cancer 1994; 73: 2680-2686. (Pubitemid 24166250)
13. Greene FL, Page DL, Flemming ID, et al.: AJCC cancer staging manual. New York: Springer; 2002.
14. Mohiuddin M, Regine WF, John WJ, et al.: Preoperative chemoradiation in fixed distal rectal cancer: Dose time factors for pathological complete response. Int J Radiat Oncol Biol Phys 2000; 46: 883-888. (Pubitemid 30114400)
15. Shia J, Guillem JG, Moore HG, et al.: Patterns of morphologic alteration in residual rectal carcinoma following preoperative chemoradiation and their association with long-term outcome. Am J Surg Pathol 2004; 28: 215-223. (Pubitemid 38124730)
16. Valentini V, Coco C, Picciocchi A, et al.: Does downstaging predict improved outcome after preoperative chemoradiation for extraperitoneal locally advanced rectal cancer? A long-term analysis of 165 patients. Int J Radiat Oncol Biol Phys 2002; 53: 664-674. (Pubitemid 34626505)
17. Berger C, de Muret A, Garaud P, et al.: Preoperative radiotherapy (RT) for rectal cancer: predictive factors of tumor downstaging and residual tumor cell density (RTCD): Prognostic implications. Int J Radiat Oncol Biol Phys 1997; 37: 619-627. (Pubitemid 27175318)
18. Kuo LJ, Liu MC, Jian JJ, et al.: Is final TNM staging a predictor for survival in locally advanced rectal cancer after preoperative chemoradiation therapy? Ann Surg Oncol 2007; 14: 2766-2772. (Pubitemid 47460637)
19. Pucciarelli S, Toppan P, Friso ML, et al.: Complete pathologic response following preoperative chemoradiation therapy for middle to lower rectal cancer is not a prognostic factor for a better outcome. Dis Colon Rectum 2004; 47: 1798-1807. (Pubitemid 40064422)
20. Wheeler JM, Dodds E, Warren BF, et al.: Preoperative chemoradiotherapy and total mesorectal excision surgery for locally advanced rectal cancer: Correlation with rectal cancer regression grade. Dis Colon Rectum 2004; 47: 2025-2031. (Pubitemid 40179060)
21. Wheeler JM, Warren BF, Mortensen NJ, et al.: Quantification of histologic regression of rectal cancer after irradiation: A proposal for a modified staging system. Dis Colon Rectum 2002; 45: 1051-1056.
22. Gavioli M, Luppi G, Losi L, et al.: Incidence and clinical impact of sterilized disease and minimal residual disease after preoperative radiochemotherapy for rectal cancer. Dis Colon Rectum 2005; 48: 1851-1857. (Pubitemid 41437667)
23. Rosenberg R, Nekarda H, Zimmermann F, et al.: Histopathological response after preoperative radiochemotherapy in rectal carcinoma is associated with improved overall survival. J Surg Oncol 2008; 97: 8-13.
24. Ruo L, Tickoo S, Klimstra DS, et al.: Long-term prognostic significance of extent of rectal cancer response to preoperative radiation and chemotherapy. Ann Surg 2002; 236: 75-81. (Pubitemid 34686453)
25. Rullier A, Laurent C, Capdepont M, et al.: Impact of tumor response on survival after radiochemotherapy in locally advanced rectal carcinoma. Am J Surg Pathol 2010; 34: 562-568.
26. Roy P, Serra S, Chetty R,: Interobserver variability in grading of response to neoadjuvant chemoradiotherapy in rectal adenocarcinomas using five grading systems. Mod Pathol 2010; 23: 165A.
27. Shia J, Tickoo SK, Guillem JG, et al.: Increased endocrine cells in treated rectal adenocarcinomas: A possible reflection of endocrine differentiation in tumor cells induced by chemotherapy and radiotherapy. Am J Surg Pathol 2002; 26: 863-872. (Pubitemid 34747638)